These data suggest that CSNK1A1, KDM2A, and LTB4R2 may be considered relevant therapeutic targets in lung cancer, warranting further investigations on the roles of these genes in different lung cancer histological subtypes. This evidence concerns the gene KDM2A and lung cancer.